APO Research
Talk to an analyst

APO RESEARCH · REPORT

Duck Virus Enteritis Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Duck Virus Enteritis Vaccine Industry Growth and Trends Forecast to 2032

22 December 202599 pages

Choose your research edition.

Industry ResearchDuck Virus Enteritis Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Duck Virus Enteritis Vaccine Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Duck Virus Enteritis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Duck Virus Enteritis Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Duck Virus Enteritis Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Duck Virus Enteritis Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Duck Virus Enteritis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Duck Virus Enteritis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Duck Virus Enteritis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Duck Virus Enteritis Vaccine include Veterinary Research Institute, Ringpu (Tianjin)Bio-Pharmacy, Chengdu TECBOND Biological, MSD Animal Health (Merck), International Duck Research Cooperative, Institute of Veterinary Preventive Medicine, Institute of Animal Health and Veterinary Biologicals and Ceva Santé Animale, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Duck Virus Enteritis Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Duck Virus Enteritis Vaccine market size, estimates, and forecasts are presented in terms of sales volume (m units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Duck Virus Enteritis Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Duck Virus Enteritis Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Duck Virus Enteritis Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Duck Virus Enteritis Vaccine Market by Company

Veterinary Research Institute

Ringpu (Tianjin)Bio-Pharmacy

Chengdu TECBOND Biological

MSD Animal Health (Merck)

International Duck Research Cooperative

Institute of Veterinary Preventive Medicine

Institute of Animal Health and Veterinary Biologicals

Ceva Santé Animale

Duck Virus Enteritis Vaccine Segment by Type

Live Vaccines

Killed Vaccines

Duck Virus Enteritis Vaccine Segment by Application

Duck

Others

Duck Virus Enteritis Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Duck Virus Enteritis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Duck Virus Enteritis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Duck Virus Enteritis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Duck Virus Enteritis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Duck Virus Enteritis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Live Vaccines Table 2. Major Company of Killed Vaccines Table 3. Global Duck Virus Enteritis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Duck Virus Enteritis Vaccine Sales by Type (2021-2026) & (m units) Table 5. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Duck Virus Enteritis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Duck Virus Enteritis Vaccine Price by Type (2021-2026) & (US$/k unit) Table 9. Global Duck Virus Enteritis Vaccine Sales by Type (2027-2032) & (m units) Table 10. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Duck Virus Enteritis Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Duck Virus Enteritis Vaccine Price by Type (2027-2032) & (US$/k unit) Table 14. North America Duck Virus Enteritis Vaccine Sales by Type (2021-2026) & (m units) Table 15. North America Duck Virus Enteritis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Duck Virus Enteritis Vaccine Sales by Type (2021-2026) & (m units) Table 17. Europe Duck Virus Enteritis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Type (2021-2026) & (m units) Table 19. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Duck Virus Enteritis Vaccine Sales by Type (2021-2026) & (m units) Table 21. Latin America Duck Virus Enteritis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Duck Virus Enteritis Vaccine Sales by Type (2021-2026) & (m units) Table 23. Middle East and Africa Duck Virus Enteritis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Duck Virus Enteritis Vaccine Industry Trends Table 25. Duck Virus Enteritis Vaccine Industry Drivers Table 26. Duck Virus Enteritis Vaccine Industry Opportunities and Challenges Table 27. Duck Virus Enteritis Vaccine Industry Restraints Table 28. Global Duck Virus Enteritis Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Duck Virus Enteritis Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Duck Virus Enteritis Vaccine Sales by Company (2021-2026) & (m units) Table 31. Global Duck Virus Enteritis Vaccine Sales Share by Company (2021-2026) Table 32. Global Duck Virus Enteritis Vaccine Market Price by Company (2021-2026) & (US$/k unit) Table 33. Global Duck Virus Enteritis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Duck Virus Enteritis Vaccine Major Company Production Sites and Headquarters Table 35. Global Duck Virus Enteritis Vaccine Company, Product Type & Application Table 36. Global Duck Virus Enteritis Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Duck Virus Enteritis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Duck Virus Enteritis Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Duck Virus Enteritis Vaccine Sales by Region (2021-2026) & (m units) Table 41. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Duck Virus Enteritis Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Duck Virus Enteritis Vaccine Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 45. Global Duck Virus Enteritis Vaccine Sales by Region (2027-2032) & (m units) Table 46. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Duck Virus Enteritis Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Duck Virus Enteritis Vaccine Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2027-2032) Table 50. Global Duck Virus Enteritis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Duck Virus Enteritis Vaccine Sales by Application (2021-2026) & (m units) Table 52. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Duck Virus Enteritis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Duck Virus Enteritis Vaccine Price by Application (2021-2026) & (US$/k unit) Table 56. Global Duck Virus Enteritis Vaccine Sales by Application (2027-2032) & (m units) Table 57. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Duck Virus Enteritis Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Duck Virus Enteritis Vaccine Price by Application (2027-2032) & (US$/k unit) Table 61. North America Duck Virus Enteritis Vaccine Sales by Application (2021-2026) & (m units) Table 62. North America Duck Virus Enteritis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Duck Virus Enteritis Vaccine Sales by Application (2021-2026) & (m units) Table 64. Europe Duck Virus Enteritis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Application (2021-2026) & (m units) Table 66. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Duck Virus Enteritis Vaccine Sales by Application (2021-2026) & (m units) Table 68. Latin America Duck Virus Enteritis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Duck Virus Enteritis Vaccine Sales by Application (2021-2026) & (m units) Table 70. Middle East and Africa Duck Virus Enteritis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Veterinary Research Institute Company Information Table 72. Veterinary Research Institute Business Overview Table 73. Veterinary Research Institute Duck Virus Enteritis Vaccine Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 74. Veterinary Research Institute Duck Virus Enteritis Vaccine Product Portfolio Table 75. Veterinary Research Institute Recent Development Table 76. Ringpu (Tianjin)Bio-Pharmacy Company Information Table 77. Ringpu (Tianjin)Bio-Pharmacy Business Overview Table 78. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 79. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Portfolio Table 80. Ringpu (Tianjin)Bio-Pharmacy Recent Development Table 81. Chengdu TECBOND Biological Company Information Table 82. Chengdu TECBOND Biological Business Overview Table 83. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 84. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Portfolio Table 85. Chengdu TECBOND Biological Recent Development Table 86. MSD Animal Health (Merck) Company Information Table 87. MSD Animal Health (Merck) Business Overview Table 88. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 89. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Portfolio Table 90. MSD Animal Health (Merck) Recent Development Table 91. International Duck Research Cooperative Company Information Table 92. International Duck Research Cooperative Business Overview Table 93. International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 94. International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Portfolio Table 95. International Duck Research Cooperative Recent Development Table 96. Institute of Veterinary Preventive Medicine Company Information Table 97. Institute of Veterinary Preventive Medicine Business Overview Table 98. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 99. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Portfolio Table 100. Institute of Veterinary Preventive Medicine Recent Development Table 101. Institute of Animal Health and Veterinary Biologicals Company Information Table 102. Institute of Animal Health and Veterinary Biologicals Business Overview Table 103. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 104. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Portfolio Table 105. Institute of Animal Health and Veterinary Biologicals Recent Development Table 106. Ceva Santé Animale Company Information Table 107. Ceva Santé Animale Business Overview Table 108. Ceva Santé Animale Duck Virus Enteritis Vaccine Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 109. Ceva Santé Animale Duck Virus Enteritis Vaccine Product Portfolio Table 110. Ceva Santé Animale Recent Development Table 111. North America Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 112. North America Duck Virus Enteritis Vaccine Sales by Country (2021-2026) & (m units) Table 113. North America Duck Virus Enteritis Vaccine Sales Market Share by Country (2021-2026) Table 114. North America Duck Virus Enteritis Vaccine Sales Forecast by Country (2027-2032) & (m units) Table 115. North America Duck Virus Enteritis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 116. North America Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Duck Virus Enteritis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Duck Virus Enteritis Vaccine Market Share by Country (2021-2026) Table 119. North America Duck Virus Enteritis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Duck Virus Enteritis Vaccine Market Share Forecast by Country (2027-2032) Table 121. Europe Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 122. Europe Duck Virus Enteritis Vaccine Sales by Country (2021-2026) & (m units) Table 123. Europe Duck Virus Enteritis Vaccine Sales Market Share by Country (2021-2026) Table 124. Europe Duck Virus Enteritis Vaccine Sales Forecast by Country (2027-2032) & (m units) Table 125. Europe Duck Virus Enteritis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Duck Virus Enteritis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Duck Virus Enteritis Vaccine Market Share by Country (2021-2026) Table 129. Europe Duck Virus Enteritis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Duck Virus Enteritis Vaccine Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Country (2021-2026) & (m units) Table 133. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Duck Virus Enteritis Vaccine Sales Forecast by Country (2027-2032) & (m units) Table 135. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Duck Virus Enteritis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Duck Virus Enteritis Vaccine Market Share by Country (2021-2026) Table 139. Asia-Pacific Duck Virus Enteritis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Duck Virus Enteritis Vaccine Market Share Forecast by Country (2027-2032) Table 141. Latin America Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 142. Latin America Duck Virus Enteritis Vaccine Sales by Country (2021-2026) & (m units) Table 143. Latin America Duck Virus Enteritis Vaccine Sales Market Share by Country (2021-2026) Table 144. Latin America Duck Virus Enteritis Vaccine Sales Forecast by Country (2027-2032) & (m units) Table 145. Latin America Duck Virus Enteritis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Duck Virus Enteritis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Duck Virus Enteritis Vaccine Market Share by Country (2021-2026) Table 149. Latin America Duck Virus Enteritis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Duck Virus Enteritis Vaccine Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Duck Virus Enteritis Vaccine Sales by Country (2021-2026) & (m units) Table 153. Middle East and Africa Duck Virus Enteritis Vaccine Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Duck Virus Enteritis Vaccine Sales Forecast by Country (2027-2032) & (m units) Table 155. Middle East and Africa Duck Virus Enteritis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Duck Virus Enteritis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Duck Virus Enteritis Vaccine Market Share by Country (2021-2026) Table 159. Middle East and Africa Duck Virus Enteritis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Duck Virus Enteritis Vaccine Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Duck Virus Enteritis Vaccine Distributors List Table 164. Duck Virus Enteritis Vaccine Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Duck Virus Enteritis Vaccine Image Figure 2. Global Duck Virus Enteritis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Duck Virus Enteritis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Duck Virus Enteritis Vaccine Sales (2021-2032) & (m units) Figure 5. Live Vaccines Image Figure 6. Global Live Vaccines Sales YoY Growth (2021-2032) & (m units) Figure 7. Killed Vaccines Image Figure 8. Global Killed Vaccines Sales YoY Growth (2021-2032) & (m units) Figure 9. Global Duck Virus Enteritis Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Duck Virus Enteritis Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Duck Virus Enteritis Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Duck Virus Enteritis Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Duck Virus Enteritis Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Duck Virus Enteritis Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Duck Virus Enteritis Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Duck Image Figure 24. Global Duck Sales YoY Growth (2021-2032) & (m units) Figure 25. Others Image Figure 26. Global Others Sales YoY Growth (2021-2032) & (m units) Figure 27. Global Duck Virus Enteritis Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Duck Virus Enteritis Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Duck Virus Enteritis Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Duck Virus Enteritis Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Duck Virus Enteritis Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Duck Virus Enteritis Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Duck Virus Enteritis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 40. North America Duck Virus Enteritis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Duck Virus Enteritis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Duck Virus Enteritis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Duck Virus Enteritis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 44. Europe Duck Virus Enteritis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Duck Virus Enteritis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Duck Virus Enteritis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 48. Asia-Pacific Duck Virus Enteritis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Duck Virus Enteritis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Duck Virus Enteritis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Duck Virus Enteritis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 52. Latin America Duck Virus Enteritis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Duck Virus Enteritis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Duck Virus Enteritis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Duck Virus Enteritis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 56. Middle East and Africa Duck Virus Enteritis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Duck Virus Enteritis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Duck Virus Enteritis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Duck Virus Enteritis Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Duck Virus Enteritis Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Duck
  • Others
Companies covered
  • Veterinary Research Institute
  • Ringpu (Tianjin)Bio-Pharmacy
  • Chengdu TECBOND Biological
  • MSD Animal Health (Merck)
  • International Duck Research Cooperative
  • Institute of Veterinary Preventive Medicine
  • Institute of Animal Health and Veterinary Biologicals
  • Ceva Santé Animale

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Duck Virus Enteritis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Duck Virus Enteritis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Duck Virus Enteritis Vaccine Market by Type
  6. 1.3.1 Live Vaccines
  7. 1.3.2 Killed Vaccines
  8. 1.4 Global Duck Virus Enteritis Vaccine Market Size by Type
  9. 1.4.1 Global Duck Virus Enteritis Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Duck Virus Enteritis Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Duck Virus Enteritis Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Duck Virus Enteritis Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Duck Virus Enteritis Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Duck Virus Enteritis Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Duck Virus Enteritis Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Duck Virus Enteritis Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Duck Virus Enteritis Vaccine Industry Trends
  2. 2.2 Duck Virus Enteritis Vaccine Industry Drivers
  3. 2.3 Duck Virus Enteritis Vaccine Industry Opportunities and Challenges
  4. 2.4 Duck Virus Enteritis Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Duck Virus Enteritis Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Duck Virus Enteritis Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Duck Virus Enteritis Vaccine Price (2021-2026)
  4. 3.4 Global Duck Virus Enteritis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Duck Virus Enteritis Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Duck Virus Enteritis Vaccine Company, Product Type & Application
  7. 3.7 Global Duck Virus Enteritis Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Duck Virus Enteritis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Duck Virus Enteritis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Duck Virus Enteritis Vaccine Tier 1, Tier 2, and Tier 3
4 Duck Virus Enteritis Vaccine Regional Status and Outlook
  1. 4.1 Global Duck Virus Enteritis Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Duck Virus Enteritis Vaccine Historic Market Size by Region
  3. 4.2.1 Global Duck Virus Enteritis Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Duck Virus Enteritis Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Duck Virus Enteritis Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Duck Virus Enteritis Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Duck Virus Enteritis Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Duck Virus Enteritis Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Duck Virus Enteritis Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Duck Virus Enteritis Vaccine by Application
  1. 5.1 Duck Virus Enteritis Vaccine Market by Application
  2. 5.1.1 Duck
  3. 5.1.2 Others
  4. 5.2 Global Duck Virus Enteritis Vaccine Market Size by Application
  5. 5.2.1 Global Duck Virus Enteritis Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Duck Virus Enteritis Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Duck Virus Enteritis Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Duck Virus Enteritis Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Duck Virus Enteritis Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Duck Virus Enteritis Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Duck Virus Enteritis Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Duck Virus Enteritis Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Veterinary Research Institute
  2. 6.1.1 Veterinary Research Institute Company Information
  3. 6.1.2 Veterinary Research Institute Business Overview
  4. 6.1.3 Veterinary Research Institute Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Veterinary Research Institute Duck Virus Enteritis Vaccine Product Portfolio
  6. 6.1.5 Veterinary Research Institute Recent Developments
  7. 6.2 Ringpu (Tianjin)Bio-Pharmacy
  8. 6.2.1 Ringpu (Tianjin)Bio-Pharmacy Company Information
  9. 6.2.2 Ringpu (Tianjin)Bio-Pharmacy Business Overview
  10. 6.2.3 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Portfolio
  12. 6.2.5 Ringpu (Tianjin)Bio-Pharmacy Recent Developments
  13. 6.3 Chengdu TECBOND Biological
  14. 6.3.1 Chengdu TECBOND Biological Company Information
  15. 6.3.2 Chengdu TECBOND Biological Business Overview
  16. 6.3.3 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Portfolio
  18. 6.3.5 Chengdu TECBOND Biological Recent Developments
  19. 6.4 MSD Animal Health (Merck)
  20. 6.4.1 MSD Animal Health (Merck) Company Information
  21. 6.4.2 MSD Animal Health (Merck) Business Overview
  22. 6.4.3 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Portfolio
  24. 6.4.5 MSD Animal Health (Merck) Recent Developments
  25. 6.5 International Duck Research Cooperative
  26. 6.5.1 International Duck Research Cooperative Company Information
  27. 6.5.2 International Duck Research Cooperative Business Overview
  28. 6.5.3 International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Portfolio
  30. 6.5.5 International Duck Research Cooperative Recent Developments
  31. 6.6 Institute of Veterinary Preventive Medicine
  32. 6.6.1 Institute of Veterinary Preventive Medicine Company Information
  33. 6.6.2 Institute of Veterinary Preventive Medicine Business Overview
  34. 6.6.3 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Portfolio
  36. 6.6.5 Institute of Veterinary Preventive Medicine Recent Developments
  37. 6.7 Institute of Animal Health and Veterinary Biologicals
  38. 6.7.1 Institute of Animal Health and Veterinary Biologicals Company Information
  39. 6.7.2 Institute of Animal Health and Veterinary Biologicals Business Overview
  40. 6.7.3 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Portfolio
  42. 6.7.5 Institute of Animal Health and Veterinary Biologicals Recent Developments
  43. 6.8 Ceva Santé Animale
  44. 6.8.1 Ceva Santé Animale Company Information
  45. 6.8.2 Ceva Santé Animale Business Overview
  46. 6.8.3 Ceva Santé Animale Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ceva Santé Animale Duck Virus Enteritis Vaccine Product Portfolio
  48. 6.8.5 Ceva Santé Animale Recent Developments
7 North America by Country
  1. 7.1 North America Duck Virus Enteritis Vaccine Sales by Country
  2. 7.1.1 North America Duck Virus Enteritis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Duck Virus Enteritis Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Duck Virus Enteritis Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Duck Virus Enteritis Vaccine Market Size by Country
  6. 7.2.1 North America Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Duck Virus Enteritis Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Duck Virus Enteritis Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Duck Virus Enteritis Vaccine Sales by Country
  2. 8.1.1 Europe Duck Virus Enteritis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Duck Virus Enteritis Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Duck Virus Enteritis Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Duck Virus Enteritis Vaccine Market Size by Country
  6. 8.2.1 Europe Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Duck Virus Enteritis Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Duck Virus Enteritis Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Duck Virus Enteritis Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Duck Virus Enteritis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Duck Virus Enteritis Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Duck Virus Enteritis Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Duck Virus Enteritis Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Duck Virus Enteritis Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Duck Virus Enteritis Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Duck Virus Enteritis Vaccine Sales by Country
  2. 10.1.1 South America Duck Virus Enteritis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Duck Virus Enteritis Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Duck Virus Enteritis Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Duck Virus Enteritis Vaccine Market Size by Country
  6. 10.2.1 South America Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Duck Virus Enteritis Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Duck Virus Enteritis Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Duck Virus Enteritis Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Duck Virus Enteritis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Duck Virus Enteritis Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Duck Virus Enteritis Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Duck Virus Enteritis Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Duck Virus Enteritis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Duck Virus Enteritis Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Duck Virus Enteritis Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Duck Virus Enteritis Vaccine Value Chain Analysis
  2. 12.1.1 Duck Virus Enteritis Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Duck Virus Enteritis Vaccine Production Mode & Process
  7. 12.2 Duck Virus Enteritis Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Duck Virus Enteritis Vaccine Distributors
  10. 12.2.3 Duck Virus Enteritis Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst